Biology of the Pathogenic Yeast Candida Glabrata

Overview

Journal Folia Microbiol (Praha)

Publisher Springer

Specialty Microbiology

Date 2006 Jul 11

PMID 16821705

Citations 16

Authors

A Bialkova

J Subik

Affiliations

Soon will be listed here.

Abstract

The yeasts, being favorite eukaryotic microorganisms used in food industry and biotechnologies for production of biomass and various substances, are also used as model organisms in genetic manipulation, molecular and biological research. In this respect, Saccharomyces cerevisiae is the best-known species but current situation in medicine and industry requires the use of other species. Here we summarize the basic taxonomic, morphological, physiological, genetic, etc. information about the pathogenic yeast Candida glabrata that is evolutionarily very closely related to baker's yeast.

Citing Articles

Humanized Candida and NanoBiT Assays Expedite Discovery of Bdf1 Bromodomain Inhibitors With Antifungal Potential.

Wei K, Arlotto M, Overhulse J, Dinh T, Zhou Y, Dupper N Adv Sci (Weinh). 2025; 12(10):e2404260.

PMID: 39821709 PMC: 11904993. DOI: 10.1002/advs.202404260.

Is There a Relationship Between Mating and Pathogenesis in Two Human Fungal Pathogens, and .

Bedekovic T, Usher J Curr Clin Microbiol Rep. 2023; 10(2):47-54.

PMID: 37151577 PMC: 10154270. DOI: 10.1007/s40588-023-00192-8.

Inositol Phosphoryl Transferase, Ipt1, Is a Critical Determinant of Azole Resistance and Virulence Phenotypes in .

Shahi G, Kumar M, Khandelwal N, Banerjee A, Sarkar P, Kumari S J Fungi (Basel). 2022; 8(7).

PMID: 35887407 PMC: 9322651. DOI: 10.3390/jof8070651.

In vitro antifungal susceptibilities of six antifungal drugs against clinical isolates according to EUCAST.

Fatahinia M, Halvaeizadeh M, Zarei Mahmoudabadi A, Aboualigalehdari E, Kiasat N Curr Med Mycol. 2021; 6(2):1-6.

PMID: 33628974 PMC: 7888517. DOI: 10.18502/CMM.6.2.2692.

, Friend and Foe.

Tam P, Gee K, Piechocinski M, Macreadie I J Fungi (Basel). 2018; 1(2):277-292.

PMID: 29376912 PMC: 5753114. DOI: 10.3390/jof1020277.

References

Buzzini P, Martini A . Large-scale screening of selected Candida maltosa, Debaryomyces hansenii and Pichia anomala killer toxin activity against pathogenic yeasts. Med Mycol. 2002; 39(6):479-82. DOI: 10.1080/mmy.39.6.479.482. View

Jarvis W . Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993; 167(5):1247-51. DOI: 10.1093/infdis/167.5.1247. View

Pfaller M, Diekema D, Boyken L, Messer S, Tendolkar S, Hollis R . Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole. J Clin Microbiol. 2003; 41(5):1875-80. PMC: 154736. DOI: 10.1128/JCM.41.5.1875-1880.2003. View

Freydiere A, Guinet R, Boiron P . Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med Mycol. 2001; 39(1):9-33. DOI: 10.1080/mmy.39.1.9.33. View

Nguyen M, Peacock Jr J, Morris A, Tanner D, Nguyen M, Snydman D . The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med. 1996; 100(6):617-23. DOI: 10.1016/s0002-9343(95)00010-0. View

Freydiere A, Perry J, Faure O, Willinger B, Tortorano A, Nicholson A . Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories. J Clin Microbiol. 2004; 42(10):4870-2. PMC: 522330. DOI: 10.1128/JCM.42.10.4870-4872.2004. View

Nakayama H, Izuta M, Nakayama N, Arisawa M, Aoki Y . Depletion of the squalene synthase (ERG9) gene does not impair growth of Candida glabrata in mice. Antimicrob Agents Chemother. 2000; 44(9):2411-8. PMC: 90078. DOI: 10.1128/AAC.44.9.2411-2418.2000. View

Moye-Rowley W . Transcriptional control of multidrug resistance in the yeast Saccharomyces. Prog Nucleic Acid Res Mol Biol. 2003; 73:251-79. DOI: 10.1016/s0079-6603(03)01008-0. View

Bouchara J, Zouhair R, LE Boudouil S, Renier G, Filmon R, Chabasse D . In-vivo selection of an azole-resistant petite mutant of Candida glabrata. J Med Microbiol. 2000; 49(11):977-984. DOI: 10.1099/0022-1317-49-11-977. View

10.

Newlon C . Yeast chromosome replication and segregation. Microbiol Rev. 1988; 52(4):568-601. PMC: 373164. DOI: 10.1128/mr.52.4.568-601.1988. View

11.

Coignard C, Hurst S, Benjamin L, Brandt M, Warnock D, Morrison C . Resolution of discrepant results for Candida species identification by using DNA probes. J Clin Microbiol. 2004; 42(2):858-61. PMC: 344520. DOI: 10.1128/JCM.42.2.858-861.2004. View

12.

Nakayama H, Izuta M, Nagahashi S, Sihta E, Sato Y, Yamazaki T . A controllable gene-expression system for the pathogenic fungus Candida glabrata. Microbiology (Reading). 1998; 144 ( Pt 9):2407-2415. DOI: 10.1099/00221287-144-9-2407. View

13.

Vazquez J, Dembry L, Sanchez V, Vazquez M, Sobel J, Dmuchowski C . Nosocomial Candida glabrata colonization: an epidemiologic study. J Clin Microbiol. 1998; 36(2):421-6. PMC: 104553. DOI: 10.1128/JCM.36.2.421-426.1998. View

14.

Hitchcock C, Pye G, Troke P, Johnson E, Warnock D . Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother. 1993; 37(9):1962-5. PMC: 188100. DOI: 10.1128/AAC.37.9.1962. View

15.

Niesters H, Goessens W, Meis J, Quint W . Rapid, polymerase chain reaction-based identification assays for Candida species. J Clin Microbiol. 1993; 31(4):904-10. PMC: 263585. DOI: 10.1128/jcm.31.4.904-910.1993. View

16.

Bussey H, Skipper N . Membrane-mediated killing of Saccharomyces cerevisiae by glycoproteins from Torulopsis glabrata. J Bacteriol. 1975; 124(1):476-83. PMC: 235916. DOI: 10.1128/jb.124.1.476-483.1975. View

17.

Gietz D, St Jean A, Woods R, Schiestl R . Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 1992; 20(6):1425. PMC: 312198. DOI: 10.1093/nar/20.6.1425. View

18.

Pfaller M, Messer S, Boyken L, Rice C, Tendolkar S, Hollis R . Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp. J Clin Microbiol. 2004; 42(7):3137-41. PMC: 446250. DOI: 10.1128/JCM.42.7.3137-3141.2004. View

19.

Petter R, Kwon-Chung K . Disruption of the SNF1 gene abolishes trehalose utilization in the pathogenic yeast Candida glabrata. Infect Immun. 1996; 64(12):5269-73. PMC: 174518. DOI: 10.1128/iai.64.12.5269-5273.1996. View

20.

Kelly S, Lamb D, Corran A, Baldwin B, Kelly D . Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta,6 alpha-diol. Biochem Biophys Res Commun. 1995; 207(3):910-5. DOI: 10.1006/bbrc.1995.1272. View